
### [MONDO:0019256](http://purl.obolibrary.org/obo/MONDO_0019256)
**Label:** sterol metabolism disorder

**Subclasses:** [MONDO:0019218](http://purl.obolibrary.org/obo/MONDO_0019218) (disorder of bile acid synthesis), [MONDO:0018841](http://purl.obolibrary.org/obo/MONDO_0018841) (congenital bile acid synthesis defect), [MONDO:0015581](http://purl.obolibrary.org/obo/MONDO_0015581) (bile acid synthesis defect with cholestasis and malabsorption), [MONDO:0017708](http://purl.obolibrary.org/obo/MONDO_0017708) (mevalonate kinase deficiency), [MONDO:0019240](http://purl.obolibrary.org/obo/MONDO_0019240) (sterol biosynthesis disorder), [MONDO:0010556](http://purl.obolibrary.org/obo/MONDO_0010556) (X-linked chondrodysplasia punctata), [MONDO:0008967](http://purl.obolibrary.org/obo/MONDO_0008967) (congenital bile acid synthesis defect 4), 

**Corr. equiv. classes:** [Orphanet:163631](http://www.orpha.net/ORDO/Orphanet_163631), [Orphanet:35173](http://www.orpha.net/ORDO/Orphanet_35173), [Orphanet:485631](http://www.orpha.net/ORDO/Orphanet_485631), [OMIM:302960](http://purl.obolibrary.org/obo/OMIM_302960), [OMIM:302950](http://purl.obolibrary.org/obo/OMIM_302950), [Orphanet:79095](http://www.orpha.net/ORDO/Orphanet_79095), [Orphanet:79195](http://www.orpha.net/ORDO/Orphanet_79195), [OMIM:214950](http://purl.obolibrary.org/obo/OMIM_214950), [Orphanet:309025](http://www.orpha.net/ORDO/Orphanet_309025), [OMIM:614307](http://purl.obolibrary.org/obo/OMIM_614307), [Orphanet:79168](http://www.orpha.net/ORDO/Orphanet_79168), 

**Class expressions from DL-Learner:**

- [HP:0001396](http://purl.obolibrary.org/obo/HP_0001396) (Cholestasis) and [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) 48.99%
- [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) and [HP:0004297](http://purl.obolibrary.org/obo/HP_0004297) (Abnormality of the biliary system) 46.37%
- [HP:0001392](http://purl.obolibrary.org/obo/HP_0001392) (Abnormality of the liver) and [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) 39.75%
- [HP:0002012](http://purl.obolibrary.org/obo/HP_0002012) (Abnormality of the abdominal organs) and [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) 37.66%
- [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) 34.64%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 34.00%
- Thing 33.99%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 33.99%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) 30.56%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) 25.93%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) 25.50%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 25.21%
- [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 21.41%
- [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) 21.38%
- [HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck) 20.71%


